Evidence map›Paper›PMID 25340122›Full record

ArticleJournal of renal injury prevention2013

Combination of metformin with other antioxidants may increase its renoprotective efficacy.

Mahmoud Rafieian-Kopaei, Azar Baradaran

Open access · greenAbstract read
In one paragraph

Article in Journal of renal injury prevention, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Diabetes mellitus and renal failure: Prevention and management.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2015
    Review
  5. Antioxidant plants and diabetes mellitus.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2015
    Review
  6. Herbal versus synthetic drugs; beliefs and facts.Journal of nephropharmacology · 2015
    Review
  7. New concepts in diabetic kidney disease.Journal of nephropharmacology · 2015
    Article
  8. Article
  9. Atherosclerosis: process, indicators, risk factors and new hopes.International journal of preventive medicine · 2014
    Review
  10. Anethum graveolens and hyperlipidemia: A randomized clinical trial.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014
    Article
  11. Metformin: Current knowledge.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014
    Review
  12. Article
  13. Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014
    Review
  14. Review
  15. Article
  16. Protective effects of herbal antioxidants on diabetic kidney disease.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Mahmoud Rafieian-KopaeiMedical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Azar BaradaranDepartment of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan University of Medical Sciences · IRShahrekord University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetic nephropathyMetforminRenoprotection

Identifiers

PMID25340122
PMCPMC4206001
OpenAlexW2101874203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.